Sino Biopharmaceutical
Manufacturing · China · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Office Tower 41st Floor Room 4109 Conven...Phone Number
+86 1059257399Website
www.sinobiopharm.comRevenue
$3.7 BillionStock Symbol
1177Industry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited and its subsidiaries are the leading innovative research and R&D-driven pharmaceutical group in China, with a business scope that covers the full industry chain of pharmaceutical R&D platforms, intelligent production and strong sales systems. Its product offerings include a variety of biological drugs and chemical drugs, and it occupies an advantageous position in many potential therapeutic fields such as liver disease, tumors, cardiovascular and cerebrovascular diseases, orthopaedics, digestive system, immune and respiratory diseases.Explore more
Sino Biopharmaceutical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sino Biopharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Sino Biopharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Sino Biopharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Sino Biopharmaceutical has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sino Biopharmaceutical
Check out if Sino Biopharmaceutical is spiking on competitors!
Click to see if Sino Biopharmaceutical had a recent Job posting/layoffs
Product Launch: Get notified when Sino Biopharmaceutical launches new products
Earning: See what the market has to say on Sino Biopharmaceutical recently announced quarterly report
Recommended Actions
Find VP level buyers at Sino Biopharmaceutical
Find more new buyers
Compare Similar Companies to Sino Biopharmaceutical
Compare insights from companies similar to Sino Biopharmaceutical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sino Biopharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sino Biopharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sino Biopharmaceutical.
Sino Biopharmaceutical Tech Stack
A closer look at the technologies used by Sino Biopharmaceutical
See more technologies
Most Recent Scoops
Project
Spending/Investment
Award
Award, Employee Engagement, Compensation & Benefits, Employee Relations, Employee Retention, Workforce Management, Company Culture & Policy, Diversity & Inclusion, HR Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Project
Spending/Investment
Award
Sino Biopharmaceutical News & Media
Sino Biopharm (1177.HK) Announces 2025 Annual Results
Development Highlights - During the Year, the Group had 4 innovative products approved for marketing by the NMPA, namely, Saitanxin(R) (Culmerciclib Capsules), Hernexeos(R) (Zongertinib Tablets), Putanning(R) (Meloxicam Injection (II)) and Anqixin(R) (Recombinant Human Coagulation Factor VIIa N01 for Injection). - In 2025, the Group’s sales of innovative products reached RMB 15.22 billion, representing a year-on-year increase of 26.2%. In addition, the Group has established multiple R&D centersMediTrust Health and Sino Biopharm Sign Strategic Cooperation Agreement at CIIE 2025 to Advance Drug-Insurance Integration New Model
HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited ("Sino Biopharm") and Shanghai MediTrust Health Technology Group Co., Ltd. ("MediTrust Health") signed a strategic cooperation agreement. The two parties will carry out in-depth cooperation around innovative drugs and commercial insurance, jointly explore a new model of drug-insurance integration, and help more patients access high-quality,Sino Biopharm (1177.HK) Announces 2025 Interim Results
Development Highlights - During the reporting period, the Group had two innovative products approved for marketing by the NMPA, namely Putanning (Meloxicam Injection (II)) and Anqixin (Recombinant Human Coagulation Factor VIIa N01 for Injection). - In the first half of 2025, the Group’s sales of innovative products reached RMB7.8 billion, a year-on-year increase of 27.2%. In addition to innovative products, the Group had 5 generic drugs approved for marketing by the NMPA. The overall revenueGlobal First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial
BEIJING, May 5, 2025 /PRNewswire/ -- Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited (1177.HK), has achieved a milestone in developing its first-in-class analgesic drug (research code: TRD205), a highly selective angiotensin II type 2 receptor (AT2R)...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sino Biopharmaceutical
Sign Up For FreeTo access detailed company insights
Sino Biopharmaceutical Limited and its subsidiaries are the leading innovative research and R&D-driven pharmaceutical group in China, with a business scope that covers the full industry chain of pharmaceutical R&D platforms, intelligent production and strong sales systems. Its product offerings include a variety of biological drugs and chemical dru... Read More
